1-16 of 16
Bernard Asselain
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P3-07-06: Comedications at Breast Cancer diagnosis impact overall survival: results from the ADRENALINE (Atlas for DRug and brEast caNcer survivAL INtEraction) study (n=235,368)

Free
Elise Dumas, Beatriz Grandal, Paul Gougis, Sophie Houzard, Aurélien Latouche, Aullène Toussaint, Samar Alsafadi, Judith Abecassis, Lidia Delrieu, Thierry Dubois, Nadir Sella, Marc Espie, Bernard Asselain, Annabelle Ballesta, Benjamin Marande, Eric Daoud, Enora Laas, Amyn Kassara, Floriane Jochum, Elaine Del Nery, Elodie Anthony, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P3-07-06.
https://doi.org/10.1158/1538-7445.SABCS22-P3-07-06
Published: 01 March 2023
View articletitled, Abstract P3-07-06: Comedications at Breast Cancer diagnosis impact overall survival: results from the ADRENALINE (Atlas for DRug and brEast caNcer survivAL INtEraction) study (n=235,368)
Journal Articles

Abstract CT231: Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy

Free
Lidia Delrieu, Anne-Sophie Hamy, Florence Coussy, Amyn Kassara, Bernard Asselain, Juliana Antero, Paul De Villèle, Elise Dumas, Nicolas Forstmann, Julien Guérin, Judicael Hotton, Christelle Jouannaud, Maud Milder, Armand Leopold, Adrien Sedeaud, Pauline Soibinet, Jean-François Toussaint, Vincent Vercamer, Enora Laas, Fabien Reyal
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT231.
https://doi.org/10.1158/1538-7445.AM2022-CT231
Published: 15 June 2022
View articletitled, Abstract CT231: Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy
Journal Articles

Abstract P4-01-12: Circulating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer

Free
Jean-Yves Pierga, Isabelle Vaucher, Maya Gutierrez, Olivier Tredan, Séverine Guiu, Gilles Romieu, Anthony Goncalves, Marc Debled, Christelle Levy, Jean-Marc Ferrero, Christelle Jouannaud, Elisabeth Luporsi, Marie-Ange Mouret-Reynier, Florence Dalenc, Bernard Asselain, Jerome Lemonnier, Francois-Clement Bidard
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-01-12.
https://doi.org/10.1158/1538-7445.SABCS14-P4-01-12
Published: 01 May 2015
View articletitled, Abstract P4-01-12: Circulating tumor cells (CTC) and endothelial cells (CEC) changes in HER2 negative metastatic breast cancer (MBC) patients treated with first line weekly paclitaxel and bevacizumab: Preliminary results of a prospective cohort from the French Breast Cancer
Journal Articles

Abstract OT3-2-06: NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer

Free
Paul H Cottu, François Duhoux, Jérôme Lemonnier, Hervé Bonnefoi, Anne Vincent Salomon, Bernard Asselain, Suzette Delaloge
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): OT3-2-06.
https://doi.org/10.1158/1538-7445.SABCS14-OT3-2-06
Published: 01 May 2015
View articletitled, Abstract OT3-2-06: NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer
Journal Articles

Abstract OT1-2-04: TP53 mutants in circulating tumor DNA and follow-up of BRCA1 mutation carriers: The CirCA01 study

Free
Francois-Clement Bidard, Dominique Stoppa-Lyonnet, Catherine Nogues, Olivier Caron, Suzette Delaloge, Catherine Dugast, Christine Lasset, Frederique Berger, Bernard Asselain, Olivier Lantz, Marc-Henri Stern, Jean-Yves Pierga
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): OT1-2-04.
https://doi.org/10.1158/1538-7445.SABCS14-OT1-2-04
Published: 01 May 2015
View articletitled, Abstract OT1-2-04: TP53 mutants in circulating tumor DNA and follow-up of BRCA1 mutation carriers: The CirCA01 study
Journal Articles

Abstract CT317: CirCe T-DM1 phase II trial: Assessing the relevance of HER2-amplified circulating tumor cells as a tool to select HER2-negative metastatic breast cancer for treatment with TDM1

Free
François-Clément Bidard, Yann de Rycke, Bernard Asselain, Paul Cottu, Manuel Rodrigues, Ronald Lebofsky, Jean-Yves Pierga
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT317.
https://doi.org/10.1158/1538-7445.AM2014-CT317
Published: 01 October 2014
View articletitled, Abstract CT317: CirCe T-DM1 phase II trial: Assessing the relevance of HER2-amplified circulating tumor cells as a tool to select HER2-negative metastatic breast cancer for treatment with TDM1
Journal Articles

Abstract 2410: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for metastatic breast cancer patients: the STIC CTC METABREAST trial.

Free
Jean-Yves Pierga, Sandrine Baffert, David Hajage, Etienne Brain, Sebastien Armanet, Cécile Simondi, Laurent Mignot, Bernard Asselain, Patricia Tresca, François-Clément Bidard
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2410.
https://doi.org/10.1158/1538-7445.AM2013-2410
Published: 15 April 2013
View articletitled, Abstract 2410: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for metastatic breast cancer patients: the STIC CTC METABREAST trial.
Journal Articles

Abstract 3208: Impact of targeted therapy on circulating tumor cells in metastatic breast cancer treated by first-line chemotherapy: IC 2006-04 study

Free
Jean-Yves Pierga, David Hajage, Thomas Bachelot, Suzette Delaloge, Etienne Brain, Mario Campone, Bernard Asselain, Claire Mathiot, François-Clément Bidard
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3208.
https://doi.org/10.1158/1538-7445.AM2011-3208
Published: 15 April 2011
View articletitled, Abstract 3208: Impact of targeted therapy on circulating tumor cells in metastatic breast cancer treated by first-line chemotherapy: IC 2006-04 study
Journal Articles

High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients

Free
Cécile Laurent, Fabien Valet, Nathalie Planque, Licia Silveri, Selma Maacha, Océane Anezo, Philippe Hupe, Corine Plancher, Cécile Reyes, Benoit Albaud, Audrey Rapinat, David Gentien, Jérôme Couturier, Xavier Sastre-Garau, Laurence Desjardins, Jean-Paul Thiery, Sergio Roman-Roman, Bernard Asselain, Emmanuel Barillot, Sophie Piperno-Neumann, Simon Saule
Journal: Cancer Research
Cancer Res (2011) 71 (3): 666–674.
https://doi.org/10.1158/0008-5472.CAN-10-0605
Published: 01 February 2011
View articletitled, High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients
Open the PDF for High PTP4A3 Phosphatase Expression Correlates with Metastatic Risk in Uveal Melanoma Patients in another window
Includes: Multimedia, Supplementary data
Journal Articles

DNA arrays predictive markers of chemosensitivity to epirubicin-cyclophosphamide (EC) then docetaxel (ECD) primary chemotherapy for localized breast cancer

Free
Sabrina Carpentier, Fabien Valet, Charles Decraene, Frederique Spyratos, Patricia de Cremoux, Jean Philippe Meyniel, Veronique Scott, Jacqueline Lehmann-Che, Brigitte Sigal, Marie-Christine Mathieu, Philippe Bertheau, Jean Marc Guinebretriere, Jean Yves Pierga, Suzette Delaloge, Etienne Brain, Michel Marty, Sergio Roman-Roman, Bernard Asselain, Emmanuel Barillot
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3620.
Published: 01 May 2008
View articletitled, DNA arrays predictive markers of chemosensitivity to epirubicin-cyclophosphamide (EC) then docetaxel (ECD) primary chemotherapy for localized breast cancer
Journal Articles

Circulating tumor cells detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a randomized phase II trial

Free
Jean-Yves Pierga, Francois-Clement Bidard, Claire Mathiot, Etienne Brain, Suzette Delaloge, Sylvie Giachetti, Norbert-Olivier Tembo, Patricia de Cremoux, Bernard Asselain, Remy Salmon, Michel Marty
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 945.
Published: 01 May 2008
View articletitled, Circulating tumor cells detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a randomized phase II trial
Journal Articles

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide (EC) followed by docetaxel (D) with or without celecoxib (Cx) or trastuzumab (Tr) according to HER2 status, as primary chemotherapy (PCT) for localized invasive breast cancer (BC) patients (pts): results of the planned interim analysis

Free
Brigitte Sigal-Zaffrani, Marie-Christine Mathieu, Philippe Bertheau, Jean Marc Guinebretiere, Jean-Yves Pierga, Suzette Delaloge, Marc Espie, Etienne Brain, Patricia De Cremoux, Frederique Spyratos, Hugues De The, Michel Marty, Bernard Asselain
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3511.
Published: 01 May 2007
View articletitled, A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide (EC) followed by docetaxel (D) with or without celecoxib (Cx) or trastuzumab (Tr) according to HER2 status, as primary chemotherapy (PCT) for localized invasive breast cancer (BC) patients (pts): results of the planned interim analysis
Journal Articles

Prophylactic salpingo-oophorectomy in a population of BRCA1 and BRCA2 carriers: experience of the Institut Curie

Free
Fatima Laki, Youlia M. Kirova, Remy Salmon, Alfred Fitoussi, Brigitte Sigal-Zafrani, Bernard Asselain, Krishna Clough, Dominique Stoppa-Lyonnet
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 213.
Published: 15 April 2006
View articletitled, Prophylactic salpingo-oophorectomy in a population of BRCA1 and BRCA2 carriers: experience of the Institut Curie
Journal Articles

Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing coexpressed genes. A study of 130 invasive ductal breast carcinomas

Free
Nicolas Stransky, Fabien Reyal, Isabelle Bernard-Pierrot, Anne Vincent-Salomon, Yann De Rycke, Paul Elvin, Andrew Cassidy, Alexander Graham, Carolyn Spraggon, Yoann Désille, Alain Fourquet, Claude Nos, Pierre Pouillart, Henri Magdelenat, Dominique Stoppa-Lyonnet, Jérôme Couturier, Brigitte Sigal-Zafrani, Bernard Asselain, Xavier Sastre-Garau, Olivier Delattre, Jean Paul Thiery, François Radvanyi
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 383.
Published: 01 May 2005
View articletitled, Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing coexpressed genes. A study of 130 invasive ductal breast carcinomas
Journal Articles

Visualizing Chromosomes as Transcriptome Correlation Maps: Evidence of Chromosomal Domains Containing Co-expressed Genes—A Study of 130 Invasive Ductal Breast Carcinomas

Free
Fabien Reyal, Nicolas Stransky, Isabelle Bernard-Pierrot, Anne Vincent-Salomon, Yann de Rycke, Paul Elvin, Andrew Cassidy, Alexander Graham, Carolyn Spraggon, Yoann Désille, Alain Fourquet, Claude Nos, Pierre Pouillart, Henri Magdelénat, Dominique Stoppa-Lyonnet, Jérôme Couturier, Brigitte Sigal-Zafrani, Bernard Asselain, Xavier Sastre-Garau, Olivier Delattre, Jean Paul Thiery, François Radvanyi
Journal: Cancer Research
Cancer Res (2005) 65 (4): 1376–1383.
https://doi.org/10.1158/0008-5472.CAN-04-2706
Published: 25 February 2005
View articletitled, Visualizing Chromosomes as Transcriptome Correlation Maps: Evidence of Chromosomal Domains Containing Co-expressed Genes—A Study of 130 Invasive Ductal Breast Carcinomas
Open the PDF for Visualizing Chromosomes as Transcriptome Correlation Maps: Evidence of Chromosomal Domains Containing Co-expressed Genes—A Study of 130 Invasive Ductal Breast Carcinomas in another window
Includes: Supplementary data
Journal Articles

Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells

Free
Sophie E. Polo, Stamatios E. Theocharis, Jerzy Klijanienko, Alexia Savignoni, Bernard Asselain, Philippe Vielh, Geneviève Almouzni
Journal: Cancer Research
Cancer Res (2004) 64 (7): 2371–2381.
https://doi.org/10.1158/0008-5472.CAN-03-2893
Published: 01 April 2004
View articletitled, Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells
Open the PDF for Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells in another window
Includes: Supplementary data